Workflow
FUTONG TECH(00465)
icon
Search documents
富通科技(00465) - 股份发行人的证券变动月报表
2025-09-01 03:33
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致:香港交易及結算所有限公司 公司名稱: 富通科技發展控股有限公司 呈交日期: 2025年9月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00465 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.1 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.1 | HKD | | 200,000,000 | 本月底法定/註冊 ...
富通科技(00465) - 2025 - 年度业绩
2025-08-22 08:35
有關截至二零一七年至 二零二四年十二月三十一日止年度年報 之補充公告 茲提述富通科技發展控股有限公司(「本公司」,連同其附屬公司統稱「本集團」)截至二零 一七年至二零二四年十二月三十一日止年度之年報(「該等年報」)。除文義另有所指外, 本公告所用詞彙與該等年報所界定者具有相同涵義。 董事會謹此根據上市規則附錄D2(「附錄D2」)第24段提供以下有關本公司前任行政總裁趙 偉先生(「趙先生」,於二零一七年十一月十七日獲委任,並自二零二四年二月一日辭任) 之酬金的補充資料。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責,對其 準確性或完整性亦不發表任何聲明,並明確表示概不就因本公告全部或任何部份內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Futong Technology Development Holdings Limited 465 趙先生於截至二零一七年至二零二四年十二月三十一日止各年度就任職本公司行政總裁 之酬金載列如下: | | | | 以股份為 | 界定供款 | | | --- | --- | --- | --- | --- | --- | | 行政總裁 | 袍 ...
富通科技发布中期业绩 股东应占亏损3269.9万元 同比扩大7.11%
Zhi Tong Cai Jing· 2025-08-21 11:51
公告称,营业额减少主要由于中国内地资讯科技市场竞争越趋激烈,加上新产品收入尚未体现,导致集 团整体收入减少。 富通科技(00465)发布截至2025年6月30日止六个月期间中期业绩,营业额5828万元(人民币,下同),同 比减少13%;股东应占亏损3269.9万元,同比扩大7.11%;每股基本亏损0.11元。 ...
富通科技(00465)发布中期业绩 股东应占亏损3269.9万元 同比扩大7.11%
智通财经网· 2025-08-21 11:48
Group 1 - The core viewpoint of the article highlights that Futong Technology (00465) reported a decline in revenue and an increase in shareholder losses for the six-month period ending June 30, 2025 [1] - The company's revenue amounted to 58.28 million RMB, representing a year-on-year decrease of 13% [1] - Shareholder losses reached 32.699 million RMB, which is an increase of 7.11% compared to the previous year [1] - The basic loss per share was reported at 0.11 RMB [1] Group 2 - The decrease in revenue is attributed to intensified competition in the information technology market in mainland China, along with the fact that new product revenues have not yet materialized [1]
富通科技(00465) - 2025 - 中期业绩
2025-08-21 11:28
香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責, 對其準確性或完整性亦不發表任何聲明,並明確表示概不就因本公佈全部或任何部 份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Futong Technology Development Holdings Limited 富 通 科 技 發 展 控 股 有 限 公 司 ( 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ) (股份代號:465) 未經審核中期業績公佈 截至二零二五年六月三十日止六個月期間 富通科技發展控股有限公司(「本公司」)董事(「董事」)會(「董事會」)欣然宣佈截至 二零二五年六月三十日止六個月期間(「本期間」)本公司及其附屬公司(統稱「本集 團」)的未經審核簡明綜合財務業績。此等簡明綜合中期財務資料並未經審核,但已 由本公司核數師及審核委員會審閱。 – 1 – | | | 二零二五年 | 二零二四年 | | --- | --- | --- | --- | | | 附註 | 六月三十日 人民幣千元 | 十二月三十一日 人民幣千元 | | | | (未經審核) | (經審核) | | 資產及負債 | | ...
富通科技(00465.HK)8月21日召开董事会会议批准中期业绩
Ge Long Hui· 2025-08-06 09:02
Core Viewpoint - Futong Technology (00465.HK) announced a board meeting scheduled for August 21, 2025, to approve the unaudited interim results for the six months ending June 30, 2025, and to consider the payment of an interim dividend, if any [1] Group 1 - The board meeting will focus on approving the company's interim performance for the first half of 2025 [1] - The results will be published on the Hong Kong Stock Exchange and the company's website [1] - The consideration of an interim dividend will be part of the agenda for the board meeting [1]
富通科技(00465) - 董事会会议通告
2025-08-06 08:52
465 董事會會議通告 富通科技發展控股有限公司(「本公司」)董事(「董事」)會(「董事會」)謹此宣佈,將於二零 二五年八月二十一日(星期四)召開董事會會議,旨在(其中包括)批准本公司及其附屬公 司於截至二零二五年六月三十日止六個月的未經審核中期業績,並於香港聯合交易所有 限公司及本公司網站上刊發相關的業績公佈及考慮派付中期股息(如有)。 承董事會命 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責,對其 準確性或完整性亦不發表任何聲明,且明確表示概不會就本公佈全部或任何部份內容而 產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Futong Technology Development Holdings Limited 富通科技發展控股有限公司 公司秘書 梁嘉龍 香港,二零二五年八月六日 於本公佈日期,執行董事為陳健先生及陳晓旋女士;而獨立非執行董事為鄒小磊先生、 羅國貴先生及姚贇先生。 ...
富通科技(00465) - 股份发行人的证券变动月报表
2025-08-01 03:54
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 公司名稱: 富通科技發展控股有限公司 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00465 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.1 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.1 | HKD | | 200,000,000 | 本月底法定/註冊股本總額: HKD 200,0 ...
富通科技(00465) - 2024 - 年度财报
2025-04-29 10:19
Digital Transformation and Innovation - The company achieved significant progress in its digital transformation strategy, focusing on AI, smart vehicles, and smart healthcare, with a strong emphasis on technological innovation and business transformation [6]. - The company launched innovative products such as "Voice of the Customer" and "Listening," leveraging AI for efficient data analysis and decision support, contributing to enhanced customer engagement [8]. - The company’s core productivity system, including AI innovation centers and multi-cloud management platforms, has become a crucial engine for driving digital transformation [6]. - The company has established the Futong Hengxian AI Innovation Center to boost its AI product development and technical service capabilities [44]. - The company emphasizes the importance of core technology in providing solutions to user pain points, aiming to enhance its market competitiveness [45]. Financial Performance - The group's revenue increased by approximately RMB 5,000,000 or 3.4% to about RMB 150,500,000 compared to the same period in 2023 [17]. - Gross profit decreased by approximately RMB 9,000,000 or 36.4% to about RMB 15,600,000, with the gross profit margin dropping from 16.9% to 10.4% due to intense competition in the Chinese IT market [18]. - Other income and net gains increased by approximately RMB 700,000 to about RMB 9,600,000, primarily due to an increase in interest income of about RMB 5,400,000 [19]. - Research and development expenses rose by approximately RMB 700,000 or 4.4% to about RMB 16,100,000, maintaining a stable level [22]. - Sales expenses decreased by approximately RMB 23,400,000 or 42.2% to about RMB 32,200,000 due to ongoing adjustments in business structure [24]. Corporate Governance - The company has appointed independent non-executive directors with extensive experience in finance and law, enhancing governance and oversight [48][49]. - The board of directors is responsible for the effective supervision of management and the strategic direction of the company, ensuring accountability and transparency [55]. - The company is committed to good corporate governance practices to enhance shareholder value and protect stakeholder rights [53]. - The board has established three board committees: Audit Committee, Remuneration Committee, and Nomination Committee, each with specific responsibilities [55]. - The company has implemented appropriate insurance arrangements for potential legal claims against its directors and executives [57]. Risk Management - The company has implemented a comprehensive risk management system to continuously identify, assess, and manage significant risks related to its business operations [83]. - The audit committee is responsible for reviewing the effectiveness of the internal control system and reporting any significant risks to the board [83]. - The board confirmed that the existing risk management and internal control systems are adequate and effective, ensuring reasonable assurance against significant misstatements or losses [86]. - The group faces risks related to reliance on a small number of major suppliers, which could significantly impact revenue and profitability if any supplier fails to meet requirements [99]. - The company faces risks related to delayed payments from customers, which may lead to impairment losses and negatively impact financial condition, profitability, and cash flow [102]. Employee and Workforce Management - As of December 31, 2024, the total employee cost was approximately RMB 92.1 million, a decrease from RMB 99.6 million in 2023, with a total of 295 employees [38]. - The company has a total of 295 employees as of December 31, 2024, with approximately 70.2% male and 29.8% female employees [79]. - The board currently consists of one female director, representing 20% of the board, with a goal to achieve gender equality in the future [79]. - The company provides training for new directors covering business operations and statutory obligations [65]. - The company has established measurable targets to achieve its diversity policy, including specific ratios of non-executive directors and members with professional qualifications [78]. Environmental, Social, and Governance (ESG) Initiatives - The company has established a clear short-term and long-term sustainable development vision and goals to achieve continuous emission reduction [155]. - The company aims to achieve carbon neutrality in Hong Kong by 2050 and in China by 2060, focusing on reducing harmful and non-harmful waste density as well as energy, water, and paper consumption to support the transition to a circular economy [176]. - The company has implemented various measures to reduce resource consumption, waste, and emissions, including centralized processing of electronic waste and promoting a low-carbon lifestyle among employees [175]. - The group received the "AI Medical Pioneer Award" at the Healthcare Industry Ecosystem Conference for its continuous innovation in AI applications in healthcare [159]. - The company strictly adheres to environmental laws and regulations in China and Hong Kong, with no significant violations reported during the reporting period [177]. Future Outlook - The company reported a positive outlook for future growth, leveraging over 20 years of industry experience and global business technology collaborations [10]. - The company anticipates that the Chinese economy will gradually stabilize in 2025, with continued growth in the IT market, particularly in AI, cloud computing, big data, and IoT [43]. - The company plans to focus on emerging technologies such as cloud computing and AI, enhancing its digital business and cloud intelligence operations [43]. - The company will closely monitor any changes in government economic and regulatory policies that may impact its business operations [106]. - The company will continue to review and monitor its environmental, social, and corporate governance performance [156].
富通科技(00465) - 2024 - 年度业绩
2025-03-25 10:53
Financial Performance - Total revenue for the year ended December 31, 2024, was RMB 150,546,000, an increase of 3.4% from RMB 145,562,000 in 2023[3] - Gross profit decreased to RMB 15,637,000, down 36.5% from RMB 24,605,000 in the previous year[3] - Operating loss narrowed to RMB 69,131,000 from RMB 83,883,000 in 2023, representing a 17.6% improvement[3] - Net loss attributable to owners was RMB 70,833,000, compared to RMB 83,299,000 in 2023, a reduction of 15%[4] - Basic and diluted loss per share improved to RMB (0.23) from RMB (0.27) in the previous year[4] - The company reported a net loss before tax of RMB 69,272,000, compared to RMB 84,025,000 in 2023, indicating a 17.5% improvement[3] - The company reported a loss of approximately RMB 70,868,000 for the year ending December 31, 2024, raising significant doubts about its ability to continue as a going concern[14] - Revenue from the enterprise management business was RMB 143,724,000 in 2024, compared to RMB 134,814,000 in 2023, reflecting an increase of 6.7%[17] - Total revenue for the company was RMB 150,546,000 in 2024, up from RMB 145,562,000 in 2023, representing a growth of 3.4%[25] - The company identified three reportable segments: enterprise management, smart health management, and smart applications, with total segment losses amounting to RMB 70,868,000 in 2024[17] Assets and Liabilities - Total assets decreased to RMB 248,850,000 from RMB 319,508,000, a decline of 22.1%[6] - Cash and cash equivalents decreased to RMB 201,806,000 from RMB 245,067,000, a drop of 17.6%[6] - Non-current assets in China decreased from RMB 69,554,000 in 2023 to RMB 52,070,000 in 2024, a decline of 25.4%[22] - The company’s total assets decreased from RMB 383,106,000 in 2023 to RMB 306,328,000 in 2024, a reduction of 20.1%[20] - Trade receivables decreased to RMB 11,136,000 from RMB 32,412,000, a reduction of approximately 65.6%[26] - The total amount of trade receivables and notes receivable was RMB 11,136,000, down from RMB 32,412,000, reflecting a significant decrease[41] - The total trade receivables at the end of the reporting period were RMB 11,118,000, down from RMB 32,412,000 in the previous year, reflecting a significant reduction in overdue amounts[43] - Trade receivables overdue for more than three months amounted to RMB 10,572,000, a decrease from RMB 26,508,000 in the previous year, indicating improved collection efforts[45] - The average credit period for purchases remained stable at 30 to 90 days, with trade payables totaling RMB 11,173,000, down from RMB 13,766,000 in the previous year[46] - The company had no bank borrowings as of December 31, 2024, maintaining a net debt-to-equity ratio of zero[69] Expenses and Costs - Research and development expenses increased to RMB 16,106,000 from RMB 15,420,000, reflecting a 4.5% rise[3] - The company reported a decrease in employee costs to RMB 92,059,000 from RMB 99,567,000, a reduction of about 7.6%[31] - Sales expenses for the year were approximately RMB 32,200,000, a decrease of about RMB 23,400,000 or 42.2% compared to the same period in 2023[60] - Administrative expenses increased to approximately RMB 35,500,000, an increase of about RMB 2,300,000 or 6.8% compared to the same period in 2023[62] - The company incurred financing costs of RMB 141,000 for lease liabilities, slightly down from RMB 142,000 in the previous year[29] Income and Other Gains - Interest income increased to RMB 10,466,000, up 105.4% from RMB 5,093,000[28] - Total other income and losses netted to RMB (974,000), compared to RMB (2,754,000) in the previous year, indicating a reduction in losses[29] - Other income and net gains amounted to approximately RMB 9,600,000, an increase of about RMB 700,000 from RMB 8,900,000 in the previous year, primarily due to an increase in interest income[56] - The company recorded a financial asset loss provision of approximately RMB 300,000, compared to a reversal of RMB 1,600,000 in the previous year, due to a long-term debtor's inability to repay[57] - Total revenue from contract liabilities recognized as income for the year was RMB 13,349,000, down from RMB 38,881,000[26] Strategic Focus and Future Plans - The company continues to focus on providing IT infrastructure products and cloud computing solutions, with no significant changes in business operations during the year[7] - The company plans to adopt IFRS 18 starting from the fiscal year ending December 31, 2026, which will require restating comparative information[12] - The company plans to terminate its smart health management business after completing existing contracts due to decreased demand for personalized health management solutions[52] - The company plans to increase R&D investment to strengthen its core competitiveness and improve operational efficiency[80] - The company aims to deepen the integration of AI technology with industry application scenarios to support enterprise-level clients in their digital transformation[79] - The company aims to accelerate business innovation and transformation by attracting high-end technology talent and enhancing market expansion[82] - Collaboration with research institutions, such as the Hong Kong Applied Science and Technology Research Institute, will focus on AI, big data, and communication technologies[80] - Despite successful cost control through business restructuring, external economic uncertainties will continue to impact the domestic market[80] - The company has established the Futong Hengxian Artificial Intelligence Innovation Center to enhance R&D and technical service capabilities in AI products[80] Dividend and Tax - The company did not recommend a final dividend for the years ended December 31, 2024, and 2023[35] - The income tax expense for the year was approximately RMB 1,600,000, an increase of about RMB 2,400,000 compared to a tax credit of RMB 800,000 in 2023[64] - The company did not recommend the payment of a final dividend for the year ending December 31, 2024[71]